DONGFENG GROUP
00489
CHINA SHENHUA
01088
CHINA COAL
01898
PETROCHINA
00857
CHINAHONGQIAO
01378
HK Stock MarketDetailed Quotes
00460 SIHUAN PHARM
- 0.690
- -0.020-2.82%
Not Open Dec 4 16:08 CST
6.42BMarket Cap-172500P/E (TTM)
0.710High0.680Low10.17MVolume0.710Open0.710Pre Close7.03MTurnover0.11%Turnover RatioLossP/E (Static)9.31BShares1.02052wk High1.33P/B6.42BFloat Cap0.46952wk Low0.02Dividend TTM9.31BShs Float6.005Historical High--Dividend LFY4.23%Amplitude0.301Historical Low0.691Avg Price1000Lot Size3.04%Div YieldTTM--Div Yield LFY
SIHUAN PHARM Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 41.88%-19.21M | 92.27%-161.26M | -158.98%-33.05M | -529.24%-2.09B | -93.16%56.04M | -33.50%486.05M | 195.11%819.48M | 129.63%730.93M | 116.08%277.68M | -222.60%-2.47B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | -41.76%-77.58M | -0.76%-147.91M | -10.96%-54.73M | -13.88%-146.79M | -64.15%-49.32M | -130.11%-128.9M | -16.92%-30.05M | 57.91%-56.02M | 51.60%-25.7M | 3.59%-133.1M |
| Interest expense - adjustment | -0.81%132.46M | 27.54%269.34M | 34.35%133.54M | 77.00%211.18M | 529.99%99.4M | 6,918.29%119.31M | 1,324.01%15.78M | -30.89%1.7M | -29.02%1.11M | -53.17%2.46M |
| Investment loss (gain) | -109.07%-4.14M | -33.70%53.62M | -4.32%45.67M | -49.00%80.88M | -5.85%47.73M | 859.70%158.58M | 308.17%50.7M | 129.82%16.52M | 75.12%12.42M | -6.84%7.19M |
| Impairment and provisions: | 194.32%7.47M | -99.81%3.47M | -105.22%-7.92M | 944.00%1.85B | --151.57M | --176.85M | ---- | ---- | ---- | --3.97B |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | --1.13B | --98.1M | ---- | ---- | ---- | ---- | --276.46M |
| -Impairmen of inventory (reversal) | -8.58%1.96M | -87.42%11.42M | -80.02%2.14M | 903.40%90.78M | --10.73M | --9.05M | ---- | ---- | ---- | ---- |
| -Impairment of trade receivables (reversal) | 154.74%5.51M | -127.96%-7.95M | -123.54%-10.06M | -22.09%28.44M | --42.75M | --36.51M | ---- | ---- | ---- | ---- |
| -Impairment of goodwill | ---- | ---- | ---- | --8.76M | ---- | ---- | ---- | ---- | ---- | --2.84B |
| -Other impairments and provisions | ---- | ---- | ---- | 347.05%586.96M | ---- | --131.3M | ---- | ---- | ---- | --851.14M |
| Revaluation surplus: | -286.33%-5.17M | -1,241.02%-131.77M | -106.27%-1.34M | 985.58%11.55M | 412.43%21.34M | 51.40%-1.3M | -259.85%-6.83M | -114.43%-2.68M | -108.64%-1.9M | 113.50%18.6M |
| -Other fair value changes | -286.33%-5.17M | -1,241.02%-131.77M | -106.27%-1.34M | 985.58%11.55M | 412.43%21.34M | 51.40%-1.3M | -259.85%-6.83M | -114.43%-2.68M | -108.64%-1.9M | 113.50%18.6M |
| Asset sale loss (gain): | -329.66%-3.52M | 91.10%-28.63M | 100.73%1.53M | -402.82%-321.57M | -7,740.12%-209.65M | 53.56%-63.95M | 1,155.38%2.74M | -2,141.78%-137.72M | -111.35%-260K | 177.92%6.75M |
| -Loss (gain) from sale of subsidiary company | ---- | 91.23%-20.69M | 100.26%558K | -255.45%-235.89M | ---211.59M | 56.57%-66.36M | ---- | ---152.8M | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | -93.60%59K | -264.40%-4.38M | 14.11%922K | 10.45%2.66M | -68.06%808K | 24.54%2.41M | 2,138.94%2.53M | -71.30%1.94M | -95.07%113K | 177.92%6.75M |
| -Loss (gain) from selling other assets | -6,733.33%-3.58M | 95.97%-3.56M | -95.26%54K | ---88.34M | 432.24%1.14M | ---- | 157.37%214K | --13.14M | ---373K | ---- |
| Depreciation and amortization: | 0.77%123.27M | -38.82%226.23M | -31.67%122.33M | 19.54%369.81M | 17.06%179.02M | 11.17%309.37M | 7.85%152.93M | -21.54%278.28M | -18.18%141.8M | 15.45%354.7M |
| -Amortization of intangible assets | 157.56%17.33M | -44.90%20.34M | -58.20%6.73M | 15.73%36.91M | 1.30%16.1M | 10.97%31.9M | 19.28%15.89M | -70.37%28.74M | -77.17%13.32M | -15.92%97.02M |
| Special items | -50.27%25.77M | -4.25%89.08M | 5.05%51.81M | 56.75%93.03M | 217.27%49.32M | 191.70%59.35M | -28,711.56%-42.06M | 5,663.74%20.35M | -16.48%147K | 2.32%353K |
| Operating profit before the change of operating capital | -30.45%179.34M | 196.47%172.18M | -25.36%257.85M | -94.79%58.08M | -64.12%345.46M | 31.01%1.12B | 137.53%962.7M | -51.67%851.36M | -68.12%405.3M | -14.88%1.76B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | 829.72%79.96M | 162.44%37.74M | -382.03%-10.96M | 73.35%-60.44M | 105.56%3.89M | -247.21%-226.81M | -155.74%-69.82M | 39.78%-65.32M | 57.33%-27.3M | -48.30%-108.48M |
| Accounts receivable (increase)decrease | -2,868.88%-141.1M | 262.39%265.79M | 101.50%5.1M | 33.26%-163.68M | 5.26%-340.27M | 9.01%-245.24M | -1,409.01%-359.17M | -214.64%-269.52M | -62.94%27.44M | 1,255.54%235.1M |
| Accounts payable increase (decrease) | 60.29%-66.9M | -147.84%-198.81M | -134.96%-168.48M | 112.28%415.54M | 198.00%481.98M | 202.26%195.75M | 170.17%161.74M | 65.37%64.76M | -165.81%-230.49M | -87.82%39.16M |
| Special items for working capital changes | 191.75%35.45M | 113.87%6.38M | 56.10%-38.63M | -254.63%-46.03M | ---88M | 121.27%29.77M | ---- | ---139.94M | ---- | ---- |
| Cash from business operations | 93.29%86.74M | 39.22%283.28M | -88.87%44.88M | -76.58%203.47M | -42.04%403.06M | 96.86%868.83M | 297.52%695.45M | -77.10%441.34M | -89.28%174.95M | -16.12%1.93B |
| Other taxs | -203.66%-50.28M | 46.62%-83.8M | 41.29%-16.56M | 22.87%-156.98M | 64.91%-28.2M | 4.99%-203.53M | 45.65%-80.36M | 57.95%-214.21M | 61.75%-147.85M | -0.92%-509.45M |
| Net cash from operations | 28.75%36.46M | 329.07%199.49M | -92.45%28.32M | -93.01%46.49M | -39.06%374.86M | 192.91%665.29M | 2,170.29%615.09M | -83.98%227.13M | -97.82%27.09M | -20.91%1.42B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 74.51%74.93M | 7.67%160.2M | 36.48%42.94M | 11.33%148.79M | -19.50%31.46M | 144.08%133.64M | 69.88%39.08M | -66.57%54.76M | -59.51%23.01M | 21.56%163.78M |
| Dividend received - investment | ---- | ---- | ---- | ---- | ---- | --317.64M | ---- | ---- | ---- | ---- |
| Loan receivable (increase) decrease | 1,079.51%119.5M | 64.77%-35.18M | 77.53%-12.2M | -348.85%-99.86M | 19.44%-54.3M | 63.56%-22.25M | -103.48%-67.4M | 11.66%-61.04M | 3.57%-33.12M | ---69.1M |
| Decrease in deposits (increase) | 486.18%136M | -101.27%-65.56M | 195.84%23.2M | -39,140.96%-32.57M | ---24.21M | 99.94%-83K | ---- | ---144.55M | ---- | ---- |
| Sale of fixed assets | -32.97%1.34M | 8.26%15.54M | -84.21%2M | 358.12%14.35M | 2,748.54%12.68M | -43.16%3.13M | -78.13%445K | 154.83%5.51M | 152.80%2.04M | 0.23%2.16M |
| Purchase of fixed assets | 34.48%-48.34M | 68.85%-125.35M | 72.12%-73.78M | 33.04%-402.46M | 17.30%-264.67M | -18.63%-601.02M | -46.13%-320.03M | -1.17%-506.64M | -64.12%-219M | -90.94%-500.79M |
| Selling intangible assets | ---- | -99.10%36K | ---- | --3.98M | ---- | ---- | ---- | ---- | ---- | ---- |
| Purchase of intangible assets | 28.13%-57.06M | 11.18%-170.07M | 3.03%-79.39M | -53.72%-191.48M | -282.17%-81.87M | -68.39%-124.57M | 71.36%-21.42M | 17.01%-73.98M | -63.15%-74.8M | 29.91%-89.13M |
| Sale of subsidiaries | ---- | -83.13%14.93M | -91.56%9.22M | --88.45M | --109.29M | ---- | ---- | --117.57M | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | -10,270.89%-153.38M | -1,517.14%-106.3M | --1.51M | --7.5M | ---- |
| Recovery of cash from investments | 269.35%3.94B | -32.25%10.47B | -87.42%1.07B | -23.48%15.45B | -9.00%8.48B | 8.60%20.19B | 43.20%9.32B | -9.85%18.59B | -30.11%6.51B | -10.76%20.63B |
| Cash on investment | -345.53%-3.91B | 39.35%-10.09B | 89.88%-877.98M | 17.14%-16.64B | 10.86%-8.68B | -6.20%-20.08B | -41.51%-9.74B | 3.41%-18.91B | 20.09%-6.88B | 9.43%-19.58B |
| Net cash from investment operations | 152.35%253.26M | 110.23%169.88M | 121.24%100.36M | -392.08%-1.66B | 47.24%-472.43M | 63.50%-337.57M | -33.82%-895.36M | -267.54%-924.78M | -223.52%-669.1M | -32.92%551.97M |
| Net cash before financing | 125.15%289.72M | 122.88%369.36M | 231.89%128.68M | -592.68%-1.61B | 65.19%-97.57M | 146.98%327.72M | 56.35%-280.26M | -135.42%-697.65M | -135.93%-642.01M | -24.69%1.97B |
| Cash flow from financing activities | ||||||||||
| New borrowing | -13.71%280.46M | -19.72%385.59M | 74.34%325.02M | -42.55%480.32M | -62.85%186.42M | -24.21%836.08M | -14.64%501.77M | 5,706.20%1.1B | --587.82M | -91.53%19M |
| Refund | -58.44%-294.82M | -26.98%-400.51M | -443.16%-186.07M | 41.85%-315.43M | 91.70%-34.26M | -44.24%-542.44M | ---412.94M | -250.49%-376.08M | ---- | 21.75%-107.3M |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | --2.74M | ---- | ---- | ---- | ---- |
| Interest paid - financing | 14.08%-23.4M | 3.05%-53.98M | -8.02%-27.23M | -99.33%-55.68M | -69.83%-25.21M | -9,911.47%-27.93M | -5,018.62%-14.84M | 33.89%-279K | -13.73%-290K | 66.43%-422K |
| Dividends paid - financing | 99.47%-1.6M | 76.39%-310.56M | 69.77%-304.56M | -569.86%-1.32B | -1,270.94%-1.01B | 86.40%-196.39M | -200.00%-73.5M | -626.52%-1.44B | 84.78%-24.5M | 17.17%-198.81M |
| Absorb investment income | -99.04%86K | -98.96%10.17M | -97.77%8.94M | 24.33%980M | 79.18%400M | -13.88%788.22M | 2,029,390.91%223.24M | --915.22M | -99.99%11K | ---- |
| Issuance expenses and redemption of securities expenses | 58.92%-13.89M | ---33.81M | ---33.81M | ---- | ---- | ---206.41M | ---29.17M | ---- | ---- | ---8.52M |
| Other items of the financing business | ---- | ---- | ---- | ---- | ---- | 1,099.80%99.98M | --113.41M | -107.57%-10M | ---- | 513.62%132.11M |
| Net cash from financing operations | 73.91%-58.32M | -75.60%-419.56M | 54.31%-223.51M | -131.83%-238.93M | -259.31%-489.21M | 306.76%750.66M | -45.30%307.07M | 210.16%184.54M | 440.33%561.37M | -26.27%-167.53M |
| Net Cash | 344.01%231.4M | 97.29%-50.2M | 83.84%-94.83M | -271.88%-1.85B | -2,288.74%-586.78M | 310.17%1.08B | 133.25%26.81M | -128.47%-513.1M | -104.97%-80.63M | -27.41%1.8B |
| Begining period cash | -1.31%3.78B | -32.62%3.83B | -32.62%3.83B | 23.42%5.68B | 23.42%5.68B | -10.03%4.6B | -10.03%4.6B | 54.37%5.12B | 54.37%5.12B | 298.49%3.31B |
| Cash at the end | 7.39%4.01B | -1.31%3.78B | -26.72%3.73B | -32.62%3.83B | 10.04%5.1B | 23.42%5.68B | -8.05%4.63B | -10.03%4.6B | 2.03%5.04B | 54.37%5.12B |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | -6.37%2.94B | ---- | --3.14B | ---- | ---- | -45.26%2.71B | ---- | --4.95B | ---- |
| Cash and cash equivalent balance | ---- | -6.37%2.94B | ---- | --3.14B | ---- | ---- | -45.26%2.71B | ---- | --4.95B | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
